NasdaqCM - Delayed Quote USD

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

34.25 +0.75 (+2.24%)
At close: April 26 at 4:00 PM EDT
34.03 -0.22 (-0.64%)
After hours: April 26 at 6:34 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CRBP

Recent News: CRBP

View More
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire 2 days ago
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
InvestorPlace 8 days ago
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
InvestorPlace 15 days ago
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
GlobeNewswire 25 days ago
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
GlobeNewswire last month
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit

Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
GlobeNewswire last month
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer

Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
GlobeNewswire last month
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire 2 months ago
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire 2 months ago
Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 214% last week

Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 214% last week
Simply Wall St. 2 months ago
Corbus Pharmaceuticals Announces Pricing of Public Offering

Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire 2 months ago
Corbus Pharmaceuticals Announces Proposed Public Offering

Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire 2 months ago
View More

Related Tickers

JANX Janux Therapeutics, Inc.
47.39
+0.62%
 
ELEV Elevation Oncology, Inc.
3.6200
-0.69%
 
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
 
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
 
APM Aptorum Group Limited
5.28
-3.65%
 
CADL Candel Therapeutics, Inc.
6.39
-0.62%
 
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
 
ANVS Annovis Bio, Inc.
18.01
+32.43%
 
ADCT ADC Therapeutics SA
4.3400
-2.25%
 
OCUL Ocular Therapeutix, Inc.
4.7450
+12.98%